ZOLL Zoll Medical Corp. (MM)

DALLAS, March 14, 2012 /PRNewswire/ -- Securities lawyers at Goldfarb LLP are investigating whether certain officers and directors of Zoll Medical Corporation (NASDAQ GS: ZOLL) violated shareholder protection laws by agreeing to a buyout offer for $93.00 per share to Asahi Kasei Corporation. Concerned ZOLL investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbllp.com about their rights and remedies for this potentially low buyout. 

"This buyout is only a 23.8% premium over ZOLL's closing stock price on March 9, 2012, and according to Bloomberg, considerably less than the 53% premium of a comparable transaction," said Hamilton Lindley. "Furthermore, an analyst covering ZOLL stock set a target price of $100 per share. Our proposed shareholder lawsuit seeks to obtain more value for shareholders than the current buyout offer." 

Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. ZOLL stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at hlindley@goldfarbllp.com or 877-583-2855 with questions or concerns.

Hamilton Lindley

Goldfarb LLP

2501 N. Harwood, Ste. 1801

Dallas, TX 75201

(877) 583-2855 Toll Free Telephone

(214) 583-2233 Local Phone Number

(214) 583-2234 Fax Number

www.goldfarbllp.com

SOURCE Goldfarb LLP